Yang Yanlei, Liu Suying, He Chengmei, Chen Zhilei, Lyu Taibiao, Zeng Liuting, Wang Li, Zhang Fengchun, Chen Hua, Zhao Robert Chunhua
Key Laboratory of the Ministry of Education, Department of Rheumatology and Clinical Immunology, Clinical Immunology Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Beijing Key Laboratory (No. BZO381), School of Basic Medicine, Center of Excellence in Tissue Engineering, Peking Union Medical College Hospital, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Front Cell Dev Biol. 2021 Jul 22;9:711005. doi: 10.3389/fcell.2021.711005. eCollection 2021.
Given the self-renewal, multi-differentiation, immunoregulatory, and tissue maintenance properties, mesenchymal stem cells (MSCs) are promising candidates for stem cell-based therapies. Breakthroughs have been made in uncovering MSCs as key contributors to homeostasis and the regenerative repair of tissues and organs derived from three germ layers. MSC differentiation into specialized cell types is sophisticatedly regulated, and accumulating evidence suggests long non-coding RNAs (lncRNAs) as the master regulators of various biological processes including the maintenance of homeostasis and multi-differentiation functions through epigenetic, transcriptional, and post-translational mechanisms. LncRNAs are ubiquitous and generally referred to as non-coding transcripts longer than 200 bp. Most lncRNAs are evolutionary conserved and species-specific; however, the weak conservation of their sequences across species does not affect their diverse biological functions. Although numerous lncRNAs have been annotated and studied, they are nevertheless only the tip of the iceberg; the rest remain to be discovered. In this review, we characterize MSC functions in homeostasis and highlight recent advances on the functions and mechanisms of lncRNAs in regulating MSC homeostasis and differentiation. We also discuss the current challenges and perspectives for understanding the roles of lncRNAs in MSC functions in homeostasis, which could help develop promising targets for MSC-based therapies.
鉴于间充质干细胞(MSCs)具有自我更新、多向分化、免疫调节和组织维持特性,它们是基于干细胞疗法的有前景的候选者。在揭示MSCs作为内环境稳态以及源自三个胚层的组织和器官再生修复的关键贡献者方面已取得突破。MSCs向特定细胞类型的分化受到复杂调控,越来越多的证据表明长链非编码RNA(lncRNAs)是各种生物学过程的主要调节因子,包括通过表观遗传、转录和翻译后机制维持内环境稳态和多向分化功能。lncRNAs普遍存在,通常指长度超过200 bp的非编码转录本。大多数lncRNAs在进化上保守且具有物种特异性;然而,它们跨物种序列的弱保守性并不影响其多样的生物学功能。尽管已经注释和研究了许多lncRNAs,但它们仍然只是冰山一角;其余的仍有待发现。在本综述中,我们描述了MSCs在内环境稳态中的功能,并强调了lncRNAs在调节MSCs内环境稳态和分化的功能及机制方面的最新进展。我们还讨论了当前在理解lncRNAs在MSCs内环境稳态功能中的作用方面的挑战和前景,这有助于为基于MSCs的疗法开发有前景的靶点。